Submission Details
| 510(k) Number | K221742 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 15, 2022 |
| Decision Date | April 21, 2023 |
| Days to Decision | 310 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K221742 is an FDA 510(k) clearance for the CONNEQT PULSE, a System, Measurement, Blood-pressure, Non-invasive (Class II — Special Controls, product code DXN), submitted by Atcor Medical (Sydney, AU). The FDA issued a Cleared decision on April 21, 2023, 310 days after receiving the submission on June 15, 2022. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1130.
| 510(k) Number | K221742 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 15, 2022 |
| Decision Date | April 21, 2023 |
| Days to Decision | 310 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXN — System, Measurement, Blood-pressure, Non-invasive |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1130 |